Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Therapeutic advances in multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that
causes significant disability and healthcare burden. The treatment of MS has evolved over …
causes significant disability and healthcare burden. The treatment of MS has evolved over …
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that
involves demyelination and axonal degeneration. Although substantial progress has been …
involves demyelination and axonal degeneration. Although substantial progress has been …
Applications of deep learning techniques for automated multiple sclerosis detection using magnetic resonance imaging: A review
Multiple Sclerosis (MS) is a type of brain disease which causes visual, sensory, and motor
problems for people with a detrimental effect on the functioning of the nervous system. In …
problems for people with a detrimental effect on the functioning of the nervous system. In …
Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
There are over 15 disease-modifying drugs that have been approved over the last 20 years
for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited …
for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited …
Treatment of multiple sclerosis—success from bench to bedside
M Tintore, A Vidal-Jordana… - Nature Reviews …, 2019 - nature.com
The modern era of multiple sclerosis (MS) treatment began 25 years ago, with the approval
of IFNβ and glatiramer acetate for the treatment of relapsing–remitting MS. Ten years later …
of IFNβ and glatiramer acetate for the treatment of relapsing–remitting MS. Ten years later …
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
Early evaluation of treatment response and prediction of disease evolution are key issues in
the management of people with multiple sclerosis (MS). In the past 20 years, MRI has …
the management of people with multiple sclerosis (MS). In the past 20 years, MRI has …
Epidemiology and treatment of multiple sclerosis in elderly populations
The prevalence of multiple sclerosis (MS) and the age of affected patients are increasing
owing to increased longevity of the general population and the availability of effective …
owing to increased longevity of the general population and the availability of effective …
[HTML][HTML] Reviewing the significance of blood–brain barrier disruption in multiple sclerosis pathology and treatment
The disruption of blood–brain barrier (BBB) for multiple sclerosis (MS) pathogenesis has a
double effect: early on during the onset of the immune attack and later for the CNS self …
double effect: early on during the onset of the immune attack and later for the CNS self …
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
Multiple sclerosis (MS) can be divided into four phenotypes based on clinical evolution. The
pathophysiological boundaries of these phenotypes are unclear, limiting treatment …
pathophysiological boundaries of these phenotypes are unclear, limiting treatment …
The COVID-19 pandemic and the use of MS disease-modifying therapies
Maria was distraught after reading about the 'potential'epidemic, yet to happen, and the
horror stories on Facebook needing reassurance and certainty about what she should do …
horror stories on Facebook needing reassurance and certainty about what she should do …